A 14% Rise in Antidepressant Purchases in Israel Since 2022
Published
The 2025 quality indicators report shows that antidepressant purchases in Israel have risen by about 14% since 2022. Antidepressants are medications that doctors prescribe to treat depression and some types of anxiety.
Alongside the increase in antidepressant purchases, the report notes a slight decline in purchases of sleep and sedative medications. In other words, in recent years more people are buying antidepressants, while the number of buyers of sleep and sedative medications has decreased slightly.
The report is based on quality indicators that examine how medications are used and the medical treatment provided. These indicators help track changes over time and make it possible to compare different regions of the country.
These figures raise an important question about the mental health of Israeli citizens. To understand the reasons for the changes, further research is needed. In the meantime, the report offers a clear picture of medication purchasing trends in recent years.
Sources: וואלה
More Israel news
- Israel and France Explore New Approaches to Mental Health Care
- Sudden Facial Paralysis and Diabetes: What a New Israeli Study Shows
- A U.S. Medical Delegation Visited Laniado Hospital in Netanya
- A Special Crossing Over Route 6: A Bridge for Wildlife
- Revolut Receives Conditional License to Establish a Bank in Israel
- Ministry of Health Cancels Water Boiling Order in Kfar Chabad
- Eisenkot and opposition leaders agree on candidates for key Knesset positions
- Exiled Iranian Prince: Iran Is Likely to Use Nuclear Weapons Against Israel